Skip to main content
Erschienen in: Infection 1/2015

01.02.2015 | Original Paper

Oseltamivir prophylaxis in controlling influenza outbreak in nursing homes: a comparison between three different approaches

verfasst von: N. Gorišek Miksić, T. Uršič, Z. Simonović, L. Lusa, P. Lobnik Rojko, M. Petrovec, F. Strle

Erschienen in: Infection | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess influenza outbreaks in nursing homes (NHs) using different pharmacological preventive measures.

Methods

We compared characteristics of influenza A outbreaks that occurred during 2011/2012 influenza season in three NHs of similar size (208, 167, and 164 residents in NH1, NH2, and NH3, respectively) implementing comparable treatment approaches and non-pharmacological outbreak control measures but different prophylactic pharmacological interventions including oseltamivir 75 mg o.d. for 10 days for all residents (NH1), for directly exposed residents (NH2), and no prophylaxis (NH3).

Results

The proportions of residents who developed acute respiratory infection (ARI) in the course of influenza outbreak were 55/208 (26.4 %) in NH1, 64/167 (38.3 %) in NH2, and 31/164 (18.9 %) in NH3; hospital admission was required in 2/55 (3.6 %), 5/64 (7.8 %), and 5/31 (16.1 %) residents of NH1, NH2, and NH3, respectively, while 1/55 (1.8 %), 1/64 (1.6 %), and 3/31 (9.7 %) residents of the corresponding NHs died during influenza outbreak. The duration of the outbreak was shorter in the NH1 where oseltamivir prophylaxis was instituted for all residents (8 days), than in NHs where selective prophylaxis with oseltamivir and no prophylaxis were used (14 and 12 days, respectively). The calculated vaccine effectiveness in residents was 48, 71, and 44 % in NH1, NH2, and NH3, respectively. Staff members had similar ARI attack rate but in comparison to residents were less often vaccinated against influenza and demonstrated higher influenza vaccine effectiveness.

Conclusions

Comparison of influenza outbreaks in three NHs revealed that the duration of the outbreak was the shortest in the NH where prophylaxis with oseltamivir was given to all residents.
Literatur
1.
Zurück zum Zitat Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86.PubMedCrossRef Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86.PubMedCrossRef
2.
Zurück zum Zitat Gaillat J, Chidiac C, Fagnani F, Pecking M, Salom M, Veyssier P, Carrat F. Morbidity and mortality associated with influenza exposure in long-term care facilities for dependent elderly people. Eur J Clin Microbiol Infect Dis. 2009;28:1077–86.PubMedCrossRef Gaillat J, Chidiac C, Fagnani F, Pecking M, Salom M, Veyssier P, Carrat F. Morbidity and mortality associated with influenza exposure in long-term care facilities for dependent elderly people. Eur J Clin Microbiol Infect Dis. 2009;28:1077–86.PubMedCrossRef
3.
Zurück zum Zitat Morens DM, Rash VM. Lessons from a nursing home outbreak of influenza A. Infect Control Hosp Epidemiol. 1995;16:275–80.PubMedCrossRef Morens DM, Rash VM. Lessons from a nursing home outbreak of influenza A. Infect Control Hosp Epidemiol. 1995;16:275–80.PubMedCrossRef
4.
Zurück zum Zitat Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005;366:1165–74.PubMedCrossRef Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005;366:1165–74.PubMedCrossRef
5.
Zurück zum Zitat Monto AS, Hornbuckle K, Ohmit SE. Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. Am J Epidemiol. 2001;154:155–60.PubMedCrossRef Monto AS, Hornbuckle K, Ohmit SE. Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. Am J Epidemiol. 2001;154:155–60.PubMedCrossRef
6.
Zurück zum Zitat Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Klimov A, Fukuda K. Effectiveness and cost-benefit of influenza vaccination of healthy working adults. A randomized controlled trial. JAMA. 2000;284:1655–63.PubMedCrossRef Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Klimov A, Fukuda K. Effectiveness and cost-benefit of influenza vaccination of healthy working adults. A randomized controlled trial. JAMA. 2000;284:1655–63.PubMedCrossRef
7.
Zurück zum Zitat Wilde JA, McMillan JA, Serwint J, Butta J, O’Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals. A randomized trial. JAMA. 1999;281:908–13.PubMedCrossRef Wilde JA, McMillan JA, Serwint J, Butta J, O’Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals. A randomized trial. JAMA. 1999;281:908–13.PubMedCrossRef
9.
Zurück zum Zitat Gavazzi G, Filali-Zegzouti Y, Guyon AC, De Wazieres B, Lejeune B, Golmard JL, Belmin J, Piette F, Rothan-Tondeur M. French Geriatric Infection Risk Institute (ORIG): French healthcare workers in geriatric healthcare settings staunchly opposed to influenza vaccination: The VESTA study. Vaccine. 2011;29:1611–6.PubMedCrossRef Gavazzi G, Filali-Zegzouti Y, Guyon AC, De Wazieres B, Lejeune B, Golmard JL, Belmin J, Piette F, Rothan-Tondeur M. French Geriatric Infection Risk Institute (ORIG): French healthcare workers in geriatric healthcare settings staunchly opposed to influenza vaccination: The VESTA study. Vaccine. 2011;29:1611–6.PubMedCrossRef
12.
Zurück zum Zitat Van der Sande MA, Ruijs WL, Meijer A, Cools HJ, van der Plas SM. Use of oseltamivir in Dutch nursing homes during the 2004-2005 influenza season. Vaccine. 2006;24:6664–9.PubMedCrossRef Van der Sande MA, Ruijs WL, Meijer A, Cools HJ, van der Plas SM. Use of oseltamivir in Dutch nursing homes during the 2004-2005 influenza season. Vaccine. 2006;24:6664–9.PubMedCrossRef
13.
Zurück zum Zitat Wutzler P, Kossow KD, Lode H, Ruf BR, Scholz H, Vogel GE, Composition of the Expert group. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. J Clin Virol. 2004;31:84–91.PubMedCrossRef Wutzler P, Kossow KD, Lode H, Ruf BR, Scholz H, Vogel GE, Composition of the Expert group. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. J Clin Virol. 2004;31:84–91.PubMedCrossRef
14.
Zurück zum Zitat Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner DA. Effectivness of neuraminidase inhibitors in treatment and prevention of influenza A and B; systematic review and meta-analyses of randomised controlled trials. BMJ. 2003;325:1235.CrossRef Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner DA. Effectivness of neuraminidase inhibitors in treatment and prevention of influenza A and B; systematic review and meta-analyses of randomised controlled trials. BMJ. 2003;325:1235.CrossRef
15.
Zurück zum Zitat Hota S, McGeer A. Antivirals and the control of influenza outbreaks. Clin Infect Dis. 2007;45:1362–8.PubMedCrossRef Hota S, McGeer A. Antivirals and the control of influenza outbreaks. Clin Infect Dis. 2007;45:1362–8.PubMedCrossRef
16.
Zurück zum Zitat McGeer A, Campbell B, Emori TG, Hierholzer WJ, Jackson JJ, Nicolle LE, Peppler C, Rivera A, Schollenberger DG, Simor AE, Smith PW, Wang EEL. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control. 1991;19:1–7.PubMedCrossRef McGeer A, Campbell B, Emori TG, Hierholzer WJ, Jackson JJ, Nicolle LE, Peppler C, Rivera A, Schollenberger DG, Simor AE, Smith PW, Wang EEL. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control. 1991;19:1–7.PubMedCrossRef
17.
Zurück zum Zitat Weinberg GA, Szilagy PG. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis. 2010;201:1607–10.PubMedCrossRef Weinberg GA, Szilagy PG. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis. 2010;201:1607–10.PubMedCrossRef
18.
Zurück zum Zitat Rainwater-Lovett K, Chun K, Lessler J. Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities. Influenza Respir Viruses. 2014;8:74–82.CrossRef Rainwater-Lovett K, Chun K, Lessler J. Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities. Influenza Respir Viruses. 2014;8:74–82.CrossRef
20.
Zurück zum Zitat Bowles SK, Lee W, Simor AE, Vearncombe M, Loeb M, Tamblyn S, Fearon M, Li Y, McGeer A. Oseltamivir compassionate use program group: use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999–2000. J Am Geriatr Soc. 2002;50:608–16.PubMedCrossRef Bowles SK, Lee W, Simor AE, Vearncombe M, Loeb M, Tamblyn S, Fearon M, Li Y, McGeer A. Oseltamivir compassionate use program group: use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999–2000. J Am Geriatr Soc. 2002;50:608–16.PubMedCrossRef
21.
Zurück zum Zitat Monto AS, Rotthoff J, Teich E, Herlocher ML, Truscon R, Yen HL, Elias S, Ohmit SE. Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clin Infect Dis. 2004;39:459–64.PubMedCrossRef Monto AS, Rotthoff J, Teich E, Herlocher ML, Truscon R, Yen HL, Elias S, Ohmit SE. Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clin Infect Dis. 2004;39:459–64.PubMedCrossRef
22.
Zurück zum Zitat Chang YM, Li WC, Huang CT, Huang CG, Tsao KC, Cheng YH, Chiang SL, Yang SY, Chen CH, Huang YC. Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan. J Hosp Infect. 2008;68:83–7.PubMedCrossRef Chang YM, Li WC, Huang CT, Huang CG, Tsao KC, Cheng YH, Chiang SL, Yang SY, Chen CH, Huang YC. Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan. J Hosp Infect. 2008;68:83–7.PubMedCrossRef
23.
Zurück zum Zitat Parker R, Loewen N, Skowronski D. Experience with oseltamivir in the control of nursing home influenza B outbreak. Can Commun Dis Rep. 2001;27:37–40.PubMed Parker R, Loewen N, Skowronski D. Experience with oseltamivir in the control of nursing home influenza B outbreak. Can Commun Dis Rep. 2001;27:37–40.PubMed
24.
Zurück zum Zitat Bush KA, McAnulty J, McPhie K, Reynolds R, Boomer M, Clarkson LM, Quaine J, Dwyer DE. Southern New South Wales public health unit: antiviral prophylaxis in the management of an influenza outbreak in an aged care facility. Commun Dis Intell. 2004;28:396–400. Bush KA, McAnulty J, McPhie K, Reynolds R, Boomer M, Clarkson LM, Quaine J, Dwyer DE. Southern New South Wales public health unit: antiviral prophylaxis in the management of an influenza outbreak in an aged care facility. Commun Dis Intell. 2004;28:396–400.
25.
Zurück zum Zitat van den Dool C, Hak E, Bonten MJ, Wallinga J. A model-based assessment of oseltamivir prophylaxis strategies to prevent influenza in nursing homes. Emerg Infect Dis. 2009;15:1547–55.PubMedCentralPubMedCrossRef van den Dool C, Hak E, Bonten MJ, Wallinga J. A model-based assessment of oseltamivir prophylaxis strategies to prevent influenza in nursing homes. Emerg Infect Dis. 2009;15:1547–55.PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Van der Sande MAB, Meijer A, Şen-Kerpiclik F, Enserink R, Cools HJM, Overduin P, Ferreira JM, Veldman-Ariessen MJ. Effectiveness of post-exposition prophylaxis with oseltamivir in nursing homes: a randomized controlled trial over four seasons. Emerg Themes Epidemiol. 2014. doi:10.1186/1742-7622-11-13. Van der Sande MAB, Meijer A, Şen-Kerpiclik F, Enserink R, Cools HJM, Overduin P, Ferreira JM, Veldman-Ariessen MJ. Effectiveness of post-exposition prophylaxis with oseltamivir in nursing homes: a randomized controlled trial over four seasons. Emerg Themes Epidemiol. 2014. doi:10.​1186/​1742-7622-11-13.
29.
Zurück zum Zitat Meijer A, Lackenby A, Hungnes O, Lina B, van der Werf S, Schweiger B, Opp M, Paget J, van de Kassteele J, Hay A, Zambon M. Oseltamivir-resistant influenza virus A (H1N1) in Europe, 2007–2008 season. Emerg Infect Dis. 2009;15:552–60.PubMedCentralPubMedCrossRef Meijer A, Lackenby A, Hungnes O, Lina B, van der Werf S, Schweiger B, Opp M, Paget J, van de Kassteele J, Hay A, Zambon M. Oseltamivir-resistant influenza virus A (H1N1) in Europe, 2007–2008 season. Emerg Infect Dis. 2009;15:552–60.PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Roussy JF, Abed J, Bouhy X, Boivin G. Emergence of an oseltamivir-resistant influenza A/H3N2 virus in an elderly patient receiving a suboptimal dose of antiviral prophylaxis. J Clin Microbiol. 2013;51:4234–6.PubMedCentralPubMedCrossRef Roussy JF, Abed J, Bouhy X, Boivin G. Emergence of an oseltamivir-resistant influenza A/H3N2 virus in an elderly patient receiving a suboptimal dose of antiviral prophylaxis. J Clin Microbiol. 2013;51:4234–6.PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, Smedley J, Murad S, Watson JM. Effectivness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomized controlled trial. BMJ. 2006. doi:10.1136/bmj.39010.581354.55. Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, Smedley J, Murad S, Watson JM. Effectivness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomized controlled trial. BMJ. 2006. doi:10.​1136/​bmj.​39010.​581354.​55.
32.
Zurück zum Zitat Carman WF, Elder AG, Wallace LA, McAullay K, Walker A, Murray GD, Stott DJ. Effect of influenza vaccination on health-care workers on mortality of elderly people in long-term care: a randomized controlled trial. Lancet. 2000;355:93–7.CrossRef Carman WF, Elder AG, Wallace LA, McAullay K, Walker A, Murray GD, Stott DJ. Effect of influenza vaccination on health-care workers on mortality of elderly people in long-term care: a randomized controlled trial. Lancet. 2000;355:93–7.CrossRef
33.
Zurück zum Zitat Castilla J, Martinez-Baz I, Martinez-Artola V, Reina G, Garcia Cenoz M, Guevara M, Moran J, Irisarri F, Arrriazu M, Albeniz E, Ezpeleta C, Barricarte A. Primary health care sentinel network; network for influenza surveillance in hospitals of Navarre: Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013; 18: pii = 20388. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20388. Castilla J, Martinez-Baz I, Martinez-Artola V, Reina G, Garcia Cenoz M, Guevara M, Moran J, Irisarri F, Arrriazu M, Albeniz E, Ezpeleta C, Barricarte A. Primary health care sentinel network; network for influenza surveillance in hospitals of Navarre: Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013; 18: pii = 20388. Available at: http://​www.​eurosurveillance​.​org/​ViewArticle.​aspx?​ArticleId=​20388.
34.
Zurück zum Zitat Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, Pitiqoi D, Rizzo C, Rebolledo J, Paradowska-Stankiewicz I, Jimenez-Jorge S, Horvath JK, Daviaud I, Guiomar R, Necula G, Bella A, O’Donnell J, Gluchowska M, Ciancio BC, Nicoll A, Moren A. Low and decreasing vaccine effectiveness against influenza A (H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicenter case-control study. Eur Surveill 2013; 18: pii: 20390. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20390. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, Pitiqoi D, Rizzo C, Rebolledo J, Paradowska-Stankiewicz I, Jimenez-Jorge S, Horvath JK, Daviaud I, Guiomar R, Necula G, Bella A, O’Donnell J, Gluchowska M, Ciancio BC, Nicoll A, Moren A. Low and decreasing vaccine effectiveness against influenza A (H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicenter case-control study. Eur Surveill 2013; 18: pii: 20390. Available at: http://​www.​eurosurveillance​.​org/​ViewArticle.​aspx?​ArticleId=​20390.
35.
Zurück zum Zitat Skowronski DM, Tweed SA, de Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis. 2008;197:490–502.PubMedCrossRef Skowronski DM, Tweed SA, de Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis. 2008;197:490–502.PubMedCrossRef
36.
Zurück zum Zitat Belongia EA, Sundaram ME, McClure DL, Meece JK, Ferdinands J, VanWormer JJ. Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Vaccine. 2014. doi:10.1016/j.vaccine.2014.06.052. Belongia EA, Sundaram ME, McClure DL, Meece JK, Ferdinands J, VanWormer JJ. Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Vaccine. 2014. doi:10.​1016/​j.​vaccine.​2014.​06.​052.
37.
Zurück zum Zitat Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ. 1997;315:1060–4.PubMedCentralPubMedCrossRef Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ. 1997;315:1060–4.PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Babcock HM, Merz LR, Fraser VJ. Is influenza an influenza-like illness? Clinical presentation of influenza in hospital patients. Infect Control Hosp Epidemiol. 2006;27:266–70.PubMedCrossRef Babcock HM, Merz LR, Fraser VJ. Is influenza an influenza-like illness? Clinical presentation of influenza in hospital patients. Infect Control Hosp Epidemiol. 2006;27:266–70.PubMedCrossRef
39.
Zurück zum Zitat Oliveira EC, Marik PE, Colice G. Influenza pneumonia: a descriptive study. Chest. 2001;119:1717–23.PubMedCrossRef Oliveira EC, Marik PE, Colice G. Influenza pneumonia: a descriptive study. Chest. 2001;119:1717–23.PubMedCrossRef
40.
Zurück zum Zitat Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus infection in older hospitalized persons. J Am Geriatr Soc. 2002;50:1498–503.PubMedCrossRef Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus infection in older hospitalized persons. J Am Geriatr Soc. 2002;50:1498–503.PubMedCrossRef
Metadaten
Titel
Oseltamivir prophylaxis in controlling influenza outbreak in nursing homes: a comparison between three different approaches
verfasst von
N. Gorišek Miksić
T. Uršič
Z. Simonović
L. Lusa
P. Lobnik Rojko
M. Petrovec
F. Strle
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 1/2015
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0703-4

Weitere Artikel der Ausgabe 1/2015

Infection 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.